Data Wizard

H. Lundbeck lines up acquisition financing for Alder

18 Sep 2019

Danish pharmaceuticals company H. Lundbeck has agreed to acquire NASDAQ-listed peer Alder BioPharmaceuticals (Alder) for USD1.95bn.

H. Lundbeck is set to fund the acquisition through its existing cash resources and bank financing.

Alder stockholders have been offered an upfront

This content is restricted, to subscribe or register for a free trial please contact , +44 20 7832 0826 or click below.

Sign up here

Already registered?

Login to your account
More »

A brief overview of our service:
View demo »

Already registered?